Clinical Trial

Estimation of Outcome and Quality of Life in ECMO Patients

Study acronym: ESTRELLA
Recruiting
View on ClinicalTrials.gov →
Summary
The availability as well as the use of extracorporeal membrane oxygenation (ECMO) systems for severe acute respiratory or cardiocirculatory failure is steadily increasing. The decision to initiate ECMO therapy is predominantly made in emergency situations, for which the focus is on acute survival. The decisions if a patient will profit from ECMO therapy are mainly made from clinical experience and educated guess by the attending team. However, it is unknown how useful these clinical predictions are. Therefore, this observational study will compare estimated and real outcome of ECMO patients.
Trial Details
NCT Number NCT06400797
Lead Sponsor Heinrich-Heine University, Duesseldorf
Conditions Extracorporeal Membrane Oxygenation
Enrollment 1,000 participants
Start Date 2024-01-01
Primary Completion 2028-01-01 (estimated)
Study Completion 2029-01-01 (estimated)
Updated on ClinicalTrials.gov 2024-05-06